Pharmacology & ToxicologybioRxivPreprint
Preclinical evaluation of Targeted IL-1β Knockdown via CD44-Immunoliposomes: A Nano-therapy against the Inflammatory Microenvironment
Haly Shukla, Simran Nasra, Milonee Patel…·Ashutosh Kumar
This paper evaluates siIL-1β-anti-CD44-Liposomes as an anti-inflammatory therapy, showing reduced pro-inflammatory cytokines and increased anti-inflammatory cytokines in macrophages.
DOI 10.1101/2025.10.17.683015